tirzepatide and fertility Fertility: Weight Loss Impact on Pregnancy Many women dealing with PCOS,

They serve as a foundation for healthcare professionals, researchers, and patients to further explore and understand the complexities of managing these chronic conditions

Kotronen, A., Juurinen, L., Tiikkainen, M., Vehkavaara, S

PubChem CID: 56843331

The FDA warns about that risk on the drug label

Indications Semaglutide is a prescription GLP-1 receptor agonist indicated: As an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with a body mass index (BMI) 30 kg/m (obesity), or 27 kg/m (overweight) in the presence of at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes, or dyslipidemia)

Competitors The market for GLP-1 support is crowded